Objective: The incidence of oral cavity cancers is increasing rapidly in South-East Asia, which may be attributable to tobacco smoking, alcohol and betel-nut chewing. However, the actual incidence and risk of second primary malignancies after oral cavity cancers have not been well established in this region. A population-based study was therefore conducted. Methods: Standardized incidence ratios and cumulative incidences were calculated for second primary cancers using the Taiwan Cancer Registry database for the period 1979-2003, which included 26 166 cases having an initial diagnosis of oral cavity cancers. Results: A 3.11-fold increase in risk for second cancer at all sites was observed after oral cavity cancers compared with the general population (standardized incidence ratio ¼ 3.11, 95% confidence interval: 2.97 -3.25). Of nine sites with excess risks of developing a second cancer, the frequency was highest in the oral/pharynx (60%), followed by lung (7.2%) and esophagus (5.5%). Second esophageal and lung cancers had a greater impact on survival compared with other types of second cancer. Notably, the risk excess was more prominent for patients with a follow-up interval of 1 year and a first primary cancer diagnosed at age of 40. These patients may justify closer surveillance. Conclusions: This is the largest population-based study with a homogeneous patient population focusing on oral cavity cancers within a high-incidence area. We found that oral cavity cancers are associated with an increased risk of nine second malignancies, which had a negative impact on survival.
INTRODUCTION
Tobacco and alcohol are the major risk factors for most cancers of the head and neck, including the oral cavity (1) . In Asia and the South Pacific, betel-nut (Areca catechu) chewing is also closely associated with oral cavity cancers, having both independent and synergistic effects with smoking and alcohol drinking (2, 3) . Oral premalignancies are common in betel-nut chewers and 10% of these undergo malignant transformation. The betel-nut chewing population is increasing in Taiwan (4, 5) . The prevalence of betel nut chewing is as high as 16 .9% (31% in men and 2.4% in women, respectively) (6), making oral cavity carcinoma the malignancy with the fastest increasing incidence (7, 8) . Its age-standardized incidence rate was increased from 6.04 per 100 000 men in 1986 to 36 in 2007 (9), strikingly higher than the incidence in the United States (7.9 per 100 000 men in 2002) (10) . Despite advances in surgery and radiation, data from the US National Cancer Institute's Surveillance, Epidemiology and End Results program showed there has been no marked change in survival rates over the past decades, which remain at 40 -50% (11) . One of the major causes of death was the high incidence of second primary malignancies that jeopardized survival rates most in patients with early-stage disease. Previous studies indicated that patients with head and neck carcinoma had an increased risk of developing second primary malignancies, for which the head and neck regions, the esophagus and the lungs are the most usual sites (12, 13) . Survival after developing second primary cancers was poor, esophagus and lung being the worst (14 -16) . The criteria for a second primary cancer were first proposed by Warren and Gates in 1932: (i) both tumors were malignant with histological confirmation, (ii) there was at least 2 cm of normal mucosa between the two tumors, except by those of same location but separated in time for 5 or more years and (iii) metastatic tumor has been excluded (17) .
Variations in the prevalence of specific risk factors account for the demographic differences in cancers of the head and neck region worldwide. Unfortunately, previous studies examining the risk of a second primary cancer following a head and neck cancer have been mostly based on small series of cases in Western patients. Thus far, it remains unclear whether there are ethnic and geographic disparities in the incidence and patterns of second primary malignancies following the oral cavity cancers. In the present study, we have analyzed the incidence and risk of second primary cancers using a population-based cohort of 26 166 patients with an initial diagnosis of oral cavity cancers in Taiwan, a prevalent area of betel-nut chewing with over 40% of head and neck cancers occurring in the oral cavity (13) .
PATIENTS AND METHODS

DATA SOURCES
With approval of the Institutional Research Ethics Committee of Chang-Gung Memorial Hospital, we quantified second cancer incidences among 29 980 patients with initial diagnoses of oral cavity carcinoma that had been reported to the Taiwan Cancer Registry (TCR) (http://www.tcr.cph.ntu.edu.tw) between 1 January 1979 and 31 December 2003. TCR was founded in 1979 and is financially supported by the National Department of Health with the aim of estimating the cancer incidence in Taiwan. The registry is assisted by a Cancer Registry Advisory Board, comprising expert members from various fields, such as pathology, clinical oncology, radiation oncology, cancer registrar and public health. It is a populationbased cancer registry that covered 22 million people in 2003. Hospitals with more than 50 beds are obligated to submit information on newly diagnosed cancer patients to the TCR, which reimburses the hospitals on the basis of numbers of cases reported in order to reduce the likelihood of under-reporting. The quality of TCR database was assured by two quality indexes: (i) the DCO% (percent of death certificate only cases) for oral and pharyngeal carcinoma (ICD-9:140 -149 except 142 and 147) ranges between 1.08 and 1.75% annually and (ii) the MV% ( percent of morphological verification) for oral cavity cancer ranges between 95 and 98% annually. All cancer registry databases in the TCR have been systemically converted to International Classification of Diseases, 9th Revision codes (18) and linked with death certificates from the National Death Database. Persons not identified by this process were therefore considered to be alive for the purpose of the current study (passive follow-up). Coding of multiple primaries followed the principles of the International Agency of Cancer Registries and the International Agency for Research on Cancer (19) . Informed consent was not required because all registry records are anonymous and open to the public. To assess the age of onset accurately, estimate person-year follow-up and minimize potentially unconfirmed cancer diagnosis in this study cohort, 3814 patients were excluded from analysis because of one or more of the following criteria: (i) missing birth dates or unknown gender (378 cases), (ii) missing last follow-up date or death status (1806 cases), (iii) having second cancer diagnosis or death occurring ,1 month after the primary oral cavity cancer (1593 cases) and (iv) age under 20 years (107 cases). As a result, the total number of cases analyzed was 26 166 cases (23 320 males and 2846 females). In current terms of chronology, second primary malignancies were classified as synchronous if they were diagnosed at the same time or within 6 months of diagnosis of the index tumor. After a 6-month follow-up period, they were defined as metachronous tumors. In our study, we excluded the cases of second cancer diagnosed ,1 month after first primary cancer or death occurring ,1 month. This exclusion criterion has been widely accepted by most population studies in the literature. The rationale is based on that for those who had been diagnosed two cancers within ,1 month, the situation might be either (i) two cancers occurred synchronously; (ii) one cancer occurred indeed later than the other cancer but was diagnosed earlier or (iii) the first cancer diagnosis was incorrect and has been revised to the latter cancer. For 'death occurring ,1 month', it was almost impossible to observe any occurrence of second cancers. Eliminating uncertain information can provide more reasonable results. However, our study criterion might eliminate a few, but not most, synchronous cases.
STATISTICAL ANALYSIS
To quantify the excess of second malignancies after diagnosis of primary oral cavity cancers, we calculated the standardized incidence ratios (SIRs) (20) and the corresponding Jpn J Clin Oncol 2011;41 (12) 1337 95% of confidence intervals (CIs) for second cancers. SIRs were taken as the ratio of the observed number (O) of second cancers to the expected number (E), which was obtained by assuming that these persons experienced the same cancer incidence as the corresponding general population. The number of person-years at risk was defined as the number of years from the date of initial primary cancer diagnosis to the date of death, date of last follow-up, date of diagnosis of a second primary cancer or the end of the study period (31 December 2003) , whichever came first. The person-years of observation for each gender, 5-year age group and 5-year period (1979 -1983, 1984 -1988, 1989 -1993, 1994 -1998, 1999 -2003) were multiplied by the incidence rates of cancers for the Taiwanese population. The corresponding products were summed over all ages and calendar years to yield the expected number of second cancer at each site. CIs of SIRs were based on the assumption that second cancer cases followed a Poisson distribution.
Cumulative incidence rates for occurrence of a second cancer were calculated in the survivors' cohort, with death treated as a competing risk according to the method described by Kalbfleisch and Prentice (21) . Briefly, it allows for the fact that patients who die are no longer at risk of second cancers, which differs from the cumulative incidence estimated by the Kaplan -Meier method that treats competing events as censored at the time of occurrence. Gray's test (22) was used to assess the statistical differences of cumulative incidence between genders. A Cox model with a timedependent covariate (23, 24) , allocating follow-up time for each patient to the non-second cancer group until second cancer occurrence, was used to compare the survival between patients without a second cancer and those with second cancers (16) . All statistical tests were two-sided and a P-value of ,0.05 was considered statistically significant.
RESULTS
PATIENT CHARACTERISITICS
Of the 26 166 cases (23 320 males and 2846 females) with oral cavity cancers diagnosed as the first malignancy and having complete data available for analysis, including cancer of the lip (ICD-9:140, 1245 cases), tongue (ICD-9:141, 9,814 cases), gum (ICD-9:143, 1733 cases), mouth floor (ICD-9:144, 697 cases) and others in oral cavity (ICD-9:145, 12 677 cases)-1800 cases (6.88%) developed a second primary malignancy during 94 086 person-years of follow-up. The characteristics of the patient population are listed in Table 1 . Within this cohort, the average follow-up time was 3.6 years, including 17 406 cases (66.52%) followed up for at least 1 year, 3927 cases (15.01%) for 5 -10 years and 2492 cases (9.52%) for .10 years. The mean age at diagnosis of first malignancy was 52.70 years. For those diagnosed as second primary cancers, the mean diagnosis age was 56.70 years, with an average interval of 3.25 years between the two primary cancers.
RISK OF SECOND CANCERS STRATIFIED BY SITE AND GENDER
SIR and corresponding 95% CIs were calculated. Irrespective of the site, the risk of developing a second primary cancer was significantly greater in both males and females with primary oral cavity cancers than in the general population (Table 2) . A total of 1800 subjects developed a subsequent cancer (SIR ¼ 3.11, 95% CI: 2.97 -3.25); 1654 males (SIR ¼ 3.29, 95% CI: 3.13 -3.45) and 146 females 
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RISK OF SECOND CANCERS STRATIFIED BY FOLLOW-UP INTERVALS
Statistically significant elevated SIRs were observed within the following cancers: oral/pharyngeal, major salivary glands, nasopharyngeal, esophageal, nasal cavity, laryngeal, lung, bone and skin. To explore the latency of development of these cancers, the SIR estimates were stratified by the interval elapsed since the first diagnosis of oral cavity cancer (Table 3 ). The entire follow-up period was divided into four consecutive intervals (1, 1 -5, 5 -10 and .10 years). The risk of developing these second cancers was highest within the first year after diagnosis of oral cavity cancers. 
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Second cancers after oral cavity cancers respectively). The risk of second esophageal and nasal cavity cancers peaked during the first year of follow-up, and remained for 10 years after diagnosis. The risk of second cancers in the salivary glands, larynx, lung, skin and bone also continued for over 5 years after diagnosis of primary oral cavity cancers.
AGE TREND OF SECOND CANCERS
To study the trend of the second cancers with age at initial diagnosis of the oral cavity cancers, we stratified their SIRs into five age groups (40, 40 -50, 50 -60, 60 -70 and .70) ( Table 4 ). The occurrence of all second primary cancers exhibited a strong trend with the onset age of oral cavity cancers. SIRs were significantly higher for patients diagnosed while young, particularly those 40 years (SIR ¼ 12.07, 95% CI: 10.54 -13.76), and tended to decline over age.
CUMULATIVE INCIDENCE RATES OF ALL SECOND CANCERS
The estimated overall risk of developing a second cancer after primary oral cavity carcinoma in the survivors' cohort was calculated, with death treated as a competing risk. For all second cancers, the overall cumulative risks at 5, 10, 15, 20 years after oral cavity cancers were estimated to be 5.95, 8.82, 10.16 and 11.77%, respectively ( Table 5 ). The cumulative incidences in male were higher than female with time, indicating that both genders were not at equal risk for all second cancers (P , 0.001; Table 5 ).
SURVIVAL IMPACT OF SECOND CANCERS ON PATIENTS WITH PRIMARY ORAL CAVITY CANCERS
The Cox model with a time-dependent covariate was employed to assess the impact of second cancers on survival (Table 6 ). Patients with occurrence of all second cancers were associated with a significantly increased risk of death compared with those without second cancers (HR ¼ 1.08, P-value ¼ 0.006). When examining the survival impact of a specific second cancer, second esophageal and lung cancers had a significantly higher risk of death (HR ¼ 1.56 and 1.53, respectively, P , 0.001 for both). Patients developing second esophageal or lung cancer had a worse survival rate than those with other second cancers (HR ¼ 2.15 and 2.58, respectively, P , 0.001 for both).
DISCUSSION
Betel-nut chewing is most common in Asia, where millions chew the product. In Taiwan, .3700 new cases of oral cavity cancers occur every year, and for all stages and sites combined, 81% of oral cavity cancer patients survive at least 1 year and the 5-year and 10-year survival rates are 50 and 40%, respectively (25) . This survival time is sufficient for survivors to develop second primary cancers. In the cohort of 26 166 patients, the incidence of second primary cancers was 6.88% (7.05% males and 5.13% females) in the mean duration of the follow-up period of 3.6 years. In Western series, the incidence varied from 5.6 to 17% (12, 15, 26, 27) . However, most studies were limited to single-institution data, prejudiced by selection bias or small sample size. Two large-scale population-based studies have been published: one was a study in South England, where of a cohort of 59 958 patients of head and neck cancers, 4.62% (5.5% males and 3.6% females), developed a second primary cancer (28) . The other was a pooled analysis from 13 cancer registries located in Europe, Australia, Canada and Singapore; of these, only 3.1% cases were in Asia. In this cohort of 99 257 patients with a first primary head and neck cancer, 10 826 (10.9%) cases developed a second primary cancer in a mean follow-up time of 4.9 years (29) . The mean follow-up of our cohort was shorter (3.6 years), and therefore the incidence would probably have increased with a longer follow-up. Therefore, we speculate that there is not ) . This time trend may be attributed by the improved database quality of TCR during last decade or the change of the coverage population size which may yield selection bias. Second primary cancers may occur because of shared environment or genetic risks, and may also be therapy related. In accordance with most Western reports (28, 29) , we found the most common sites with excess risk were in the upper aerodigestive tract, including the oral/ pharynx, major salivary glands, nasopharynx, esophagus, nasal cavity, larynx and lung. Field cancerization (30) was proposed to explain the development of multiple tumors by shared common risk factors, where the carcinogenic effects of alcohol, tobacco and betel-nut may simultaneously act on the entire mucosa of mouth, pharynx and aerodigestive tract to trigger the development of multiple cancers independent of each other (31) . In contrast to Western studies, we found an excess risk of bone and skin (non-melanoma) cancers in our cohort. During the past 25 years in Taiwan, oral cavity cancer treatment-including surgery, chemotherapy regimens and radiation therapy-have been similar to that given in Western countries. Therefore, it probably reflected genetic factors or geographic variations (32) . The reduction of risk for the second gastric and prostate cancers (SIR ¼ 0.58 and 0.61, respectively) remains obscure. A large-scale population study from South England also showed a similar trend (SIR ¼ 0.97 for stomach and 0.73 for prostate) (28) . Field cancerization theory cannot provide an explanation for this because neither of these two tumors were squamous cell carcinomas. More work is needed to identify their associations with oral cavity cancers.
Our study design is insufficient to link betel-nut chewing and the increased risk for second primaries. The study simply confirmed the high risk of second primary in oral cavity cancer patients in a high-risk area. In general agreement with previous reports in other countries (12, 29) , our series confirmed the frequency of second primary malignancies was highest in oral/pharynx (60%, 1079/1800), followed by lung (7.2%, 130/1800) and esophagus (5.5%, 99/1800). The trend toward the risk for second malignancies being greater in younger patients was consistent with findings in Western patients (29) . The risk excess was most prominent for patients with a first primary cancer diagnosed at the age of 40. Different genetic susceptibility in young patients, which predisposes them to multiple tumors, might contribute to this association. The lower baseline risk for cancer in the younger population could also cause a higher magnitude of excess risk (33) . In this analysis, the risk was strikingly high for those with follow-up interval of 1 and 1-5 years. The average interval between primary index oral cavity tumor and the second cancer was 3.25 years, which is in accordance with other studies, ranging from 2 to 4 years (34 -36). Thus, a greater vigilance should be taken during first 5 years after initial diagnosis of oral cancer. However, we could not exclude the possibility that the observed excess risk identified in the first year of follow-up might be due to more frequent examination (surveillance bias) or misclassification of a metastasis as a second primary.
Notably, we found second primary cancers had a significant negative impact on survival, especially esophageal (HR ¼ 1.56, P , 0.001) and lung (HR ¼ 1.53, P , 0.001) cancers compared with those with other types of second cancers. The median survival after developing these two types of second cancers did not exceed 1 year. Poor prognosis could be attributable to late diagnosis or, in certain patients, the inability to receive radical therapy due to previous treatment for the first malignancy. An early diagnosis of asymptomatic esophageal or lung cancer could enable treatment with less aggressive strategies, for example, endoscopic mucosal resection or video-assisted thoracoscopic surgery, respectively, which might prolong survival. Therefore, a more effective program of surveillance for these two sites cannot be overemphasized.
In conclusion, the major strength of our study is the size of the cohort from a homogeneous patient population, which provides a more accurate estimation of the incidence and patterns of second primary malignancies for Asian patients. Our data confirmed that head and neck regions, esophagus and lung are the most usual sites for second malignancies, which had a great impact on the survival of patients who survived oral cavity cancers. More intense follow-up surveillance might be indicated for high-risk group such as younger patients and those diagnosed .5 years.
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